SCHEMBL22693268

SCHEMBL22693268

C#C/C=C(C(\C#N)=C/C)/N1CCC(Nc2cc(C(=O)N3CCN(c4ccccc4)CC3)c(C)cc2C)CC1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MTOR P42345 4/20 0.49
RPTOR Q8N122 4/20 0.49
MLST8 Q9BVC4 4/20 0.49
ALDH1A1 P00352 3/20 0.40
TSHR P16473 2/20 0.40
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
USP2 O75604 1/20 0.38
USP30 Q70CQ3 1/20 0.38
DCTPP1 Q9H773 1/20 0.37
EGFR P00533 1/20 0.37
ERBB2 P04626 1/20 0.37
LMNA P02545 2/20 0.37
TP53 P04637 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
RECQL P46063 2/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22693231 0.88 MTOR (0.43) MTORRPTORMLST8USP30SMN1; SMN2
SCHEMBL22693230 0.88 MTOR (0.43) MTORRPTORMLST8LMNATP53
SCHEMBL22693232 0.88 MTOR (0.47) MTORRPTORMLST8ALDH1A1TSHR
SCHEMBL22693225 0.88 MTOR (0.54) MTORRPTORMLST8ALDH1A1TSHR
SCHEMBL22693175 0.87 MTOR (0.48) MTORRPTORMLST8ALDH1A1SMN1; SMN2
SCHEMBL22693149 0.86 MTOR (0.52) MTORRPTORMLST8SMN1; SMN2
SCHEMBL22693115 0.86 MTOR (0.52) MTORRPTORMLST8SMN1; SMN2
SCHEMBL22693180 0.86 MTOR (0.56) MTORRPTORMLST8ALDH1A1LMNA
SCHEMBL22693236 0.86 MTOR (0.51) MTORRPTORMLST8ALDH1A1KMT2A
SCHEMBL22693171 0.86 MTOR (0.41) MTORRPTORMLST8DCTPP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2020-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.